An Official Website of the United States Government
Company Information:
Name:
TIGEN PHARMACEUTICALS
Address:
UNIVERSITY OF KENTUCKY
ASTECC BLDG, RM 346
LEXINGTON, KY 40506
ASTECC BLDG, RM 346
LEXINGTON, KY 40506
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
(606) 257-2300
Award Totals:
Award List:
STABLE CAMPTOTHECIN FORMULATIONS FOR CANCER TREATMENT
Award Year / Program / Phase:
1998 / STTR / Phase I
Agency:
HHS
Research Institution:
Stehlin Foundation For Cancer Research
Principal Investigator:
Burke
Award Amount:
$100,000.00
RI Contact:
N/A
Long Circulating Liposomal Camptothecins CAP and EAP
Award Year / Program / Phase:
2001 / STTR / Phase I
Agency:
HHS
Research Institution:
NEW YORK UNIVERSITY OF MEDICINE
Abstract:
DESCRIPTION (provided by applicant): Based on the extensive data generated
during the phase I portion of our studies, there is sufficient and compelling
information to support the further development of the highly lipophilic and
blood-stable topoisomerase inhibitor, DB-67.… More
Potent Topoisomerase I Inhibition For Glioma Therapy
Award Year / Program / Phase:
2001 / STTR / Phase I
Agency:
HHS
Research Institution:
UNIVERSITY OF KENTUCKY
Abstract:
DESCRIPTION (PROVIDED BY APPLICANT): DB-67 is a promising new silatecan
(silylcamptothecin) analog that displays superior blood stability relative to
the FDA-approved camptothecin congeners, topotecan and CPT- 11. DB-67 also
exhibits a high degree of anti-cancer potency… More